MOLECULAR PATHWAYS IN HEAD AND NECK CANCER: UNRAVELING THE GENETIC, EPIGENETIC, AND ENVIRONMENTAL FACTORS CONTRIBUTING TO TUMOR DEVELOPMENT AND METASTASIS

Abstract

Head and neck cancer, and especially head and neck squamous cell carcinoma is a heterogeneous type of malignancy with foreboding influences of genetic, epigenetic, and environmental factors. The advances in multi-omics analysis have helped in gaining some knowledge regarding the molecular pathways related to tumor initiation, progression, and metastasis. This review discusses various major genetic mutations like TP53, PIK3CA, and CDKN2A, as well as epigenetic modifications like DNA methylation and histone modification. The study also discusses the tumor microenvironment, particularly the interplay between stromal constituents, immune cells, and metabolic changes that contribute to tumor growth and resistance to therapy. The comprehension of these underlying mechanisms would assist in constructing an avenue for precision medicine to counteract these specific aberrations and improve patient outcomes. Molecular mechanisms of HNSCC need to be understood to develop effective treatment strategies. Genetic mutations, epigenetic changes, and interactions within the TME act synergistically to promote tumor progression and therapy resistance. Precision medicine, immunotherapy, and targeted therapies hold a great deal of promise in improving patient outcomes. With focus, tumor heterogeneity, and therapy resistance collectively pose challenges to the goals of research and innovation in cancer biology and treatment. It has been concluded that this integrated molecular perspective provides valuable insights for precision medicine approaches, highlighting potential biomarkers and therapeutic targets for improved clinical outcomes in HNC patients. Future studies should focus on integrating multi-omics data with artificial intelligence-driven models to enhance early detection and personalized treatment strategies.